Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Xefo 4mg*


Contraindicated
Foetal cardiopulmonary toxicity & renal dysfunction. Inhibition of uterine contractions

Contraindicated
Xefo 4mg* :
Type Medicine Non Marketed
Originator B
Agent Century Pharma
Distributor Century Pharma
Laboratory Takeda
Responsible Party Nycomed Austria GmbH
Origin Austria
Manufacturer Nycomed Austria GmbH
Origin Austria
ATC M01AC05

Your comment will appear shortly after approval

Xefo 4mg* :

Revision Date : 1/12/2012


Effect Frequency
Abdominal pain Very Common
Agitation Rare
Agranulocytosis Very rare
Allergic reaction Rare
Alopecia Common
Anaemia Uncommon
Appetite disorder Very Common
Asthma Uncommon
Bleeding time prolonged Rare
Blood pressure abnormal Rare
Cardiac failure Rare
Central nervous system disorder Common
Chest pain Rare
Conjunctivitis Uncommon
Constipation Very Common
Depression Common
Dermatitis Common
Diarrhoea (Diarrhea) Very Common
Dry mouth (Xerostomia) Very Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Common
Dyspepsia Very Common
Dysphagia Very Common
Dyspnoea (dyspnea) Uncommon
Ear buzzing Uncommon
Ecchymosis Common
Enzyme abnormality Very Common
Eructation (belching) Very Common
Fatigue Common
Flatulence Very Common
Gastritis Very Common
Gastrointestinal bleeding Very Common
Gastrointestinal disorders Very Common
Gastrooesophageal reflux disease Very Common
Glossitis Uncommon
Haemorrhoids Rare
Headache Common
Hearing impaired Uncommon
Hepatic dysfunction Very Common
Hot flush Uncommon
Inappetence Very Common
Insomnia Common
Leg cramps Common
Leucopenia (Leukopenia) Rare
Micturition disorder Rare
Migraine Common
Myalgia Uncommon
Nausea Very Common
Oedema Uncommon
Oesophagitis Rare
Palpitations Uncommon
Paraesthesia (paresthesia) Common
Peptic ulcer Very Common
Photosensitivity Uncommon
Pruritus Common
Psychiatric disorders Common
Rectal bleeding Rare
Rhinitis allergic Uncommon
Skin Eruption Common
Stomatitis Very Common
Sweating Common
Tachycardia Uncommon
Thrombocytopenia (Thrombopenia) Rare
Tremor Common
Upper abdominal discomfort Uncommon
Upper respiratory tract infection Rare
Urticaria Uncommon
Vertigo Common
Visual disturbance Uncommon
Vomiting Very Common
Weakness Rare
Weight decreased (Weight loss) Uncommon
Weight increased (weight gain) Rare

Different Units By MoH Code

Xefo 4mg*  MoH 3314 :
Form Tablet, Film-Coated
Package Size Box of 30
Strength 4mg
NSSF ✘
Quarantine ✘
Reg. Number 973330/01
Submission date 01/01/2001
Registration Year 2001
Archived Date 2014


Price Comparison

● Country: Switzerland
● Package Size: 50
● Public Price: 15.65 CHF ( 1,618,523.00 LBP )
● Pack size unit used: 50
● Cost/Unit: 0,313 CHF ( 0.00 LBP )
● Exfactory Price: 6.5 CHF
● Pricing Date: 04/03/2020
● Type: Medicine Non Marketed

● Country: Greece
● Package Size: 20
● Public Price: 2.26 EUR ( 218,939.76 LBP )
● Pack size unit used: 20
● Cost/Unit: 0,113 EUR ( 0.00 LBP )
● Exfactory Price: 1.56 EUR
● Pharmacy Price: 1.64 EUR ( 158876.64 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

● Country: Ireland
● Package Size: 30
● Public Price: 3.07 EUR ( 297,409.32 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,1023 EUR ( 0.00 LBP )
● Exfactory Price: 3 EUR
● Pricing Date: 09/10/2020
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 100
● Reference: Danish Medicine Agency
● Pricing Date: 20/02/2019
● Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info